[Bronchopulmonary dysplasia (BPD)]

E Herting1

  • 1Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Deutschland.

Insights

Bronchopulmonary dysplasia (BPD) has evolved from an old form linked to mechanical ventilation to a new form in premature infants. New BPD survivors face long-term multisystem health challenges.

Area of Science:

  • Neonatal medicine
  • Pediatric pulmonology
  • Developmental biology

Context:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants.
  • Historically, 'old' BPD resulted from mechanical ventilation and oxygen, causing lung fibrosis.
  • Modern surfactant therapy has increased survival, leading to 'new' BPD, characterized by impaired alveolar and capillary development.

Purpose:

  • To differentiate between the historical and current forms of BPD.
  • To highlight the distinct pathological mechanisms and clinical implications of 'new' BPD.
  • To underscore the long-term health consequences for survivors.

Summary:

  • 'Old' BPD was a fibroproliferative lung disease in premature infants due to ventilation and oxygen.
  • 'New' BPD, emerging with increased survival from surfactant therapy, involves arrested lung development and multisystem immaturity.
  • Survivors of 'new' BPD may experience persistent lung, cardiovascular, growth, and neurodevelopmental issues into adulthood.

Impact:

  • Understanding the evolution of BPD is crucial for developing targeted therapies.
  • Recognizing the multisystem nature of 'new' BPD necessitates comprehensive long-term follow-up.
  • Research into growth factors and stem cells shows promise for future BPD treatment strategies.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.8K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
63.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K